Realcan Pharmaceutical Group Co.,Ltd. Posted 1.7 Billion Yuan Net Loss in 2022

Realcan Pharmaceutical Group Co.,Ltd. (瑞康医药集团股份有限公司) (002589.SZ) reported a net loss of 1.7 billion yuan in 2022, reversing a net profit of 382 million yuan for the previous year.

Meanwhile, the company posted 12.3 billion yuan in revenue, down 41.5% year-on-year.

At the end of the reporting period, it had 18.3 billion yuan in total assets and 12.6 billion yuan in total liabilities, with a liability-to-asset ratio of 68.6%.